Risk of diarrhoea due to Clostridium difficile during cefotaxime treatment. Cefotaxime compares favourably with other third generation cephalosporins.
Rothschild
E
E
Rauss
A
A
Danan
G
G
D002439:Cefotaxime / Q000009:adverse effects*; D002511:Cephalosporins / Q000009:adverse effects*; D003967:Diarrhea / Q000382:microbiology*; D004761:Enterocolitis, Pseudomembranous / Q000209:etiology*; D006801:Humans
D002511:Cephalosporins; D002439:Cefotaxime